Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Retlaw5on Dec 09, 2008 3:34pm
421 Views
Post# 15635671

PARTNER

PARTNERThis is what I heard:
Most likely based on past experience and orders but in confidence
till announcements come from Govt.
One needs to build inventory in advance of demand surge....
Unlike the snow tire debacle in Quebec...
(whom also should have warned the tire guys)

Retlaw

We have a high measure of confidence that this company is Octopharma - a very credible European company, 2500 employees in 27 countries c/w 5 state of the art production facilities in Austria, France, Sweden, Mexico and Germany.  Top line revenue for 2007 was 752 million Euro's.
This would not be the first deal they have done with ProMetic.
 
I know its difficult, but hang in there......
Bullboard Posts